Analgesia Additive Interaction between Tadalafil and Morphine in Experimental Animal Model.

Since both morphine and tadalafil have been proven to exert some of their analgesic activity through modulation of the NO-cGMP pathway, the aim of the current study is to evaluate the pharmacologic interaction between tadalafil and morphine in order to decrease the dose of morphine and subsequently its side effects. The assessment was carried out through isobolographic analysis relative to ED50s of both morphine and tadalafil obtained by tail-flick test on BALB/c mice. Morphine and tadalafil ED50s calculated from the dose-response curves were 8303 µg/kg and 2080 µ/kg, respectively. The experimental ED50 values of morphine and tadalafil in their mixture were 4800 µ/kg and 1210 µ/kg, respectively. Those results showed an additive interaction between morphine and tadalafil presented by a total fraction value for the mixture of 1160 µ/kg. This outcome can be interpreted by the fact that both drugs share common pathways namely, NO-cGMP and opioid receptors. As a conclusion, morphine and tadalafil combination showed an additive effect against acute pain, which is mediated through the central nervous system, thus providing a rationale for combining them in order to decrease morphine dose and thus minimizing its side effect.

[1]  J. Bidlack,et al.  Behavioral pharmacology of the mixed-action delta-selective opioid receptor agonist BBI-11008: studies on acute, inflammatory and neuropathic pain, respiration, and drug self-administration , 2020, Psychopharmacology.

[2]  Jun-Xu Li Combining opioids and non-opioids for pain management: Current status , 2019, Neuropharmacology.

[3]  S. Negus,et al.  Core Outcome Measures in Preclinical Assessment of Candidate Analgesics , 2019, Pharmacological Reviews.

[4]  M. Mehanna,et al.  Antinociceptive effect of tadalafil in various pain models: Involvement of opioid receptors and nitric oxide cyclic GMP pathway , 2018, Toxicology and applied pharmacology.

[5]  A. Moreira,et al.  Potential anti-inflammatory effect of LQFM-021 in carrageenan-induced inflammation: The role of nitric oxide. , 2017, Nitric oxide : biology and chemistry.

[6]  A. Masi,et al.  Kynurenic acid and zaprinast induce analgesia by modulating HCN channels through GPR35 activation , 2016, Neuropharmacology.

[7]  G. Sadan,et al.  Antinociceptive Effect of Vardenafil on Carrageenan-Induced Hyperalgesia in Rat: involvement of Nitric Oxide/Cyclic Guanosine Monophosphate/Calcium Channels Pathway , 2015, Iranian journal of pharmaceutical research : IJPR.

[8]  C. Upasani,et al.  Involvement of NO–cGMP pathway in anti-hyperalgesic effect of PDE5 inhibitor tadalafil in experimental hyperalgesia , 2015, Inflammopharmacology.

[9]  K. Hassanzadeh,et al.  Simvastatin prevents morphine antinociceptive tolerance and withdrawal symptoms in rats. , 2015, Journal of the Formosan Medical Association = Taiwan yi zhi.

[10]  L. Lião,et al.  Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021). , 2015, Nitric oxide : biology and chemistry.

[11]  H. Miranda,et al.  Isobolographic analysis of the opioid-opioid interactions in a tonic and a phasic mouse model of induced nociceptive pain , 2014, Journal of Biomedical Science.

[12]  J. Sawynok,et al.  Contributions of peripheral, spinal, and supraspinal actions to analgesia. , 2014, European journal of pharmacology.

[13]  G. Pasternak Opiate pharmacology and relief of pain. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Jaykaran Charan,et al.  How to calculate sample size in animal studies? , 2013, Journal of pharmacology & pharmacotherapeutics.

[15]  A. Ceylan,et al.  The synergistic antinociceptive interactions of morphine and dexmedetomidine in rats with nerve-ligation injury. , 2013, Hippokratia.

[16]  S. Fleming,et al.  Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease , 2013, Journal of visualized experiments : JoVE.

[17]  R. Tallarida,et al.  Quantitative methods for assessing drug synergism. , 2011, Genes & cancer.

[18]  FQ Cunha,et al.  Tadalafil analgesia in experimental arthritis involves suppression of intra‐articular TNF release , 2011, British journal of pharmacology.

[19]  A. Altun,et al.  The nitric oxide-cGMP signaling pathway plays a significant role in tolerance to the analgesic effect of morphine. , 2011, Canadian journal of physiology and pharmacology.

[20]  H. Loh,et al.  Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene , 2010, Journal of Biomedical Science.

[21]  David Julius,et al.  Cellular and Molecular Mechanisms of Pain , 2009, Cell.

[22]  C. Carson Tadalafil for the treatment of erectile dysfunction. , 2008, Current urology reports.

[23]  W. Kim,et al.  Additive Antinociception between Intrathecal Sildenafil and Morphine in the Rat Formalin Test , 2008, Journal of Korean medical science.

[24]  Gary M. Pollack,et al.  Opioid Tolerance Development: A Pharmacokinetic/Pharmacodynamic Perspective , 2008, The AAPS Journal.

[25]  P. Flood,et al.  The Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia , 2008, Anesthesia and analgesia.

[26]  J. N. Sharma,et al.  Role of nitric oxide in inflammatory diseases , 2007, Inflammopharmacology.

[27]  A. Malmberg,et al.  Models of Nociception: Hot‐Plate, Tail‐Flick, and Formalin Tests in Rodents , 2007, Current protocols in neuroscience.

[28]  H. Bae,et al.  Synergistic antinociception between zaprinast and morphine in the spinal cord of rats on the formalin test , 2006, European journal of anaesthesiology.

[29]  J. Corbin,et al.  Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction , 2005, Expert opinion on drug metabolism & toxicology.

[30]  V. Granados-Soto,et al.  Analysis of the mechanism underlying the peripheral antinociceptive action of sildenafil in the formalin test. , 2005, European journal of pharmacology.

[31]  A. Bella,et al.  Tadalafil in the treatment of erectile dysfunction , 2003, Current urology reports.

[32]  J. Choi,et al.  Pharmacologic Interaction between Cannabinoid and either Clonidine or Neostigmine in the Rat Formalin Test , 2003, Anesthesiology.

[33]  J. E. Torres-López,et al.  Peripheral Antinociceptive Action of Morphine and the Synergistic Interaction with Lamotrigine , 2002, Anesthesiology.

[34]  M. Hammarlund-Udenaes,et al.  Aspects on tail-flick, hot-plate and electrical stimulation tests for morphine antinociception. , 1998, Pharmacology & toxicology.

[35]  V. Granados-Soto,et al.  Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. , 1997, European journal of pharmacology.

[36]  L. Merkel Zaprinast: A cGMP-Selective Phosphodiesterase Inhibitor , 1993 .

[37]  M. Fennessy,et al.  Comparison of the dose‐response effects of morphine on brain amines, analgesia and activity in mice , 1972, British journal of pharmacology.

[38]  Y. Yeh,et al.  Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia. , 2009, British journal of anaesthesia.